Suppr超能文献

溶组织内阿米巴在通过胞饮作用获得人补体调节蛋白后,发展出对补体沉积和裂解的抗性。

Entamoeba histolytica Develops Resistance to Complement Deposition and Lysis after Acquisition of Human Complement-Regulatory Proteins through Trogocytosis.

机构信息

Department of Microbiology and Molecular Genetics, University of California, Davisgrid.27860.3b, Davis, California, USA.

出版信息

mBio. 2022 Apr 26;13(2):e0316321. doi: 10.1128/mbio.03163-21. Epub 2022 Mar 1.

Abstract

Entamoeba histolytica is the cause of amoebiasis. The trophozoite (amoeba) form of this parasite is capable of invading the intestine and can disseminate through the bloodstream to other organs. The mechanisms that allow amoebae to evade complement deposition during dissemination have not been well characterized. We previously discovered a novel complement-evasion mechanism employed by E. histolytica. E. histolytica ingests small bites of living human cells in a process termed trogocytosis. We demonstrated that amoebae were protected from lysis by human serum following trogocytosis of human cells and that amoebae acquired and displayed human membrane proteins from the cells they ingested. Here, we aimed to define how amoebae are protected from complement lysis after performing trogocytosis. We found that amoebae were protected from complement lysis after ingestion of both human Jurkat T cells and red blood cells and that the level of protection correlated with the amount of material ingested. Trogocytosis of human cells led to a reduction in deposition of C3b on the surface of amoebae. We asked whether display of human complement regulators is involved in amoebic protection, and found that CD59 was displayed by amoebae after trogocytosis. Deletion of a single complement-regulatory protein, CD59 or CD46, from Jurkat cells was not sufficient to alter amoebic protection from lysis, suggesting that multiple, redundant complement regulators mediate amoebic protection. However, exogeneous expression of CD46 or CD55 in amoebae was sufficient to confer protection from lysis. These studies shed light on a novel strategy for immune evasion by a pathogen. Entamoeba histolytica is the cause of amoebiasis, a diarrheal disease of global importance. While infection is often asymptomatic, the trophozoite (amoeba) form of this parasite is capable of invading and ulcerating the intestine and can disseminate through the bloodstream to other organs. Understanding how E. histolytica evades the complement system during dissemination is of great interest. Here, we demonstrate for the first time that amoebae that have performed trogocytosis (nibbling of human cells) resist deposition of the complement protein C3b. Amoebae that have performed trogocytosis display the complement-regulatory protein CD59. Overall, our studies suggest that acquisition and display of multiple, redundant complement regulators is involved in amoebic protection from complement lysis. These findings shed light on a novel strategy for immune evasion by a pathogen. Since other parasites use trogocytosis for cell killing, our findings may apply to the pathogenesis of other infections.

摘要

溶组织内阿米巴是引起阿米巴病的原因。这种寄生虫的滋养体(变形虫)形式能够侵入肠道,并通过血液传播到其他器官。目前尚未很好地描述允许阿米巴在传播过程中逃避补体沉积的机制。我们之前发现了溶组织内阿米巴采用的一种新的补体逃避机制。溶组织内阿米巴在一个称为胞饮作用的过程中摄取小块活的人体细胞。我们证明,在吞噬了人体细胞后,阿米巴可以免受人血清的溶解,并且阿米巴从它们吞噬的细胞中获得并显示人体膜蛋白。在这里,我们旨在定义在进行胞饮作用后,阿米巴如何免受补体溶解。我们发现,在吞噬了人 Jurkat T 细胞和红细胞后,阿米巴免受补体溶解的保护,并且保护水平与摄入的物质量相关。吞噬人体细胞导致阿米巴表面 C3b 的沉积减少。我们询问显示人体补体调节剂是否参与阿米巴的保护作用,发现吞噬作用后阿米巴显示 CD59。从 Jurkat 细胞中删除单个补体调节蛋白 CD59 或 CD46 不足以改变阿米巴免受溶解的保护作用,这表明多种冗余的补体调节蛋白介导阿米巴的保护作用。然而,在阿米巴中表达外源性 CD46 或 CD55 足以赋予其对溶解的保护作用。这些研究揭示了病原体免疫逃避的一种新策略。

溶组织内阿米巴是引起阿米巴病的原因,这是一种具有全球重要性的腹泻病。虽然感染通常无症状,但这种寄生虫的滋养体(变形虫)形式能够侵入和溃疡肠道,并通过血液传播到其他器官。了解溶组织内阿米巴在传播过程中如何逃避补体系统非常重要。在这里,我们首次证明进行胞饮作用(吞噬人体细胞)的阿米巴抵抗补体蛋白 C3b 的沉积。进行了胞饮作用的阿米巴显示出补体调节蛋白 CD59。总的来说,我们的研究表明,获得和显示多种冗余的补体调节剂参与了阿米巴免受补体溶解的保护作用。这些发现揭示了病原体免疫逃避的一种新策略。由于其他寄生虫使用胞饮作用进行细胞杀伤,我们的发现可能适用于其他感染的发病机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ad1/8941920/54e637123924/mbio.03163-21-f001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验